Z-VDVAD-FMK, caspase-2 inhibitor
Be the first to review this product! Submit a review
|
(0 Publication)
- FuncS
Unknown
Functional Studies - Z-VDVAD-FMK, caspase-2 inhibitor (AB142035)
ab13847 staining active caspase 3 in SKNSH cells treated with Z-VDVAD-FMK (ab142035), by ICC/IF. Decrease in active caspase 3 expression correlates with increased concentration of Z-VDVAD-FMK, as described in literature.
The cells were incubated at 37°C for 1 hour in media containing different concentrations of ab142035 (Z-VDVAD-FMK) in DMSO. After this incupation 10 µM of camptothecin (ab120115) was added to all samples and the cells were incubated for further 24 hours. The samples were then fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab13847 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with
- Chemical Structure
Lab
Chemical Structure - Z-VDVAD-FMK, caspase-2 inhibitor (AB142035)
2D chemical structure image of ab142035, Z-VDVAD-FMK, caspase-2 inhibitor
Complementary Products
Product details
Properties and storage information
Shipped at conditions
Appropriate long-term storage conditions
Storage information
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com